These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 30667544)

  • 41. Ciclopirox delivery into the human nail plate using novel lipid diffusion enhancers.
    Hafeez F; Hui X; Selner M; Rosenthal B; Maibach H
    Drug Dev Ind Pharm; 2014 Jun; 40(6):838-44. PubMed ID: 23600655
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative efficacy and safety of amorolfine nail lacquer 2% versus 5% once weekly.
    Lauharanta J
    Clin Exp Dermatol; 1992 Sep; 17 Suppl 1():41-3. PubMed ID: 1458664
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Discoloration of the nail plate due to the misuse of amorolfine 5% nail lacquer.
    Rigopoulos D; Katsambas A; Antoniou C; Christofidou E; Balaskas E; Stratigos J
    Acta Derm Venereol; 1996 Jan; 76(1):83-4. PubMed ID: 8721508
    [No Abstract]   [Full Text] [Related]  

  • 44. Efficacy of amorolfine nail lacquer for the prophylaxis of onychomycosis over 3 years.
    Sigurgeirsson B; Olafsson JH; Steinsson JT; Kerrouche N; Sidou F
    J Eur Acad Dermatol Venereol; 2010 Aug; 24(8):910-5. PubMed ID: 20028447
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Determination of the efficacy of terbinafine hydrochloride nail solution in the topical treatment of dermatophytosis in a guinea pig model.
    Ghannoum MA; Long L; Pfister WR
    Mycoses; 2009 Jan; 52(1):35-43. PubMed ID: 18498299
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Validation of bovine hoof slices as a model for infected human toenails: in vitro ciclopirox transungual permeation.
    Monti D; Saccomani L; Chetoni P; Burgalassi S; Tampucci S; Mailland F
    Br J Dermatol; 2011 Jul; 165(1):99-105. PubMed ID: 21410668
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparative clinical evaluation of efficacy and safety of a formulation containing ciclopirox 8% in the form of a therapeutic nail lacquer in two different posologies for the treatment of onychomycosis of the toes.
    Schalka S; Nunes S; Gomes Neto A
    An Bras Dermatol; 2012; 87(1):19-25. PubMed ID: 22481647
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Therapeutic efficacy of topically applied KP-103 against experimental tinea unguium in guinea pigs in comparison with amorolfine and terbinafine.
    Tatsumi Y; Yokoo M; Senda H; Kakehi K
    Antimicrob Agents Chemother; 2002 Dec; 46(12):3797-801. PubMed ID: 12435679
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development of ciclopirox nail lacquer with enhanced permeation and retention.
    Thapa RK; Choi JY; Go TG; Kang MH; Han SD; Jun JH; Son MW; Yong CS; Kim JO
    Arch Pharm Res; 2016 Jul; 39(7):953-9. PubMed ID: 27306785
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy Coefficients Determined Using Nail Permeability and Antifungal Activity in Keratin-Containing Media Are Useful for Predicting Clinical Efficacies of Topical Drugs for Onychomycosis.
    Matsuda Y; Sugiura K; Hashimoto T; Ueda A; Konno Y; Tatsumi Y
    PLoS One; 2016; 11(7):e0159661. PubMed ID: 27441843
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Distribution of Luliconazole in Nail Plate by In Vitro Permeation and Efficacy by Zone of Inhibition Test after Treatment of Luliconazole Nail Solution].
    Shimamura T; Miyamae A; Arai M; Minemura A; Nozawa A; Kubota N
    Med Mycol J; 2016; 57(1):J19-25. PubMed ID: 26936348
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of a fractional 2940-nm Er:YAG laser and 5% amorolfine lacquer combination therapy versus a 5% amorolfine lacquer monotherapy for the treatment of onychomycosis: a randomized controlled trial.
    Zhang J; Zhang Y; Qin J; Lu S; Cai W; Li J; Huang H; Yang S; Xi L
    Lasers Med Sci; 2021 Feb; 36(1):147-152. PubMed ID: 32557000
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ciclopirox nail lacquer for the treatment of onychomycosis: an open non-comparative study.
    Shemer A; Nathansohn N; Trau H; Amichai B; Grunwald MH
    J Dermatol; 2010 Feb; 37(2):137-9. PubMed ID: 20175847
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Infected nail plate model made of human hair keratin for evaluating the efficacy of different topical antifungal formulations against Trichophyton rubrum in vitro.
    Lusiana ; Reichl S; Müller-Goymann CC
    Eur J Pharm Biopharm; 2013 Aug; 84(3):599-605. PubMed ID: 23419812
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Optimized Ciclopirox-Based Eudragit RLPO Nail Lacquer: Effect of Endopeptidase Enzyme as Permeation Enhancer on Transungual Drug Delivery and Efficiency Against Onychomycosis.
    Khattab A; Shalaby S
    AAPS PharmSciTech; 2018 Apr; 19(3):1048-1060. PubMed ID: 29138987
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of the antifungal efficacy of terbinafine hydrochloride and ciclopirox olamine containing formulations against the dermatophyte Trichophyton rubrum in an infected nail plate model.
    Täuber A; Müller-Goymann CC
    Mol Pharm; 2014 Jul; 11(7):1991-6. PubMed ID: 24490976
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Scytalidium hyalinum onychomycosis successfully treated with 5% amorolfine nail lacquer.
    Downs AM; Lear JT; Archer CB
    Br J Dermatol; 1999 Mar; 140(3):555. PubMed ID: 10233295
    [No Abstract]   [Full Text] [Related]  

  • 58. Topical treatment of onychomycosis with amorolfine 5% nail lacquer: comparative efficacy and tolerability of once and twice weekly use.
    Reinel D
    Dermatology; 1992; 184 Suppl 1():21-4. PubMed ID: 1532336
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ciclopirox delivery into the human nail plate.
    Hui X; Wester RC; Barbadillo S; Lee C; Patel B; Wortzmman M; Gans EH; Maibach HI
    J Pharm Sci; 2004 Oct; 93(10):2545-8. PubMed ID: 15349963
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transungual Penetration and Antifungal Activity of Prescription and Over-the-Counter Topical Antifungals: Ex Vivo Comparison.
    Elabbasi A; Kadry A; Joseph W; Elewski B; Ghannoum M
    Dermatol Ther (Heidelb); 2024 Sep; 14(9):2495-2507. PubMed ID: 39133361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.